Home >  News >  August, 2014

Drug Maker Introduces 10 mL Propofol

Smaller portions reduce waste and support safety.

Published: August 12, 2014

During the recent propofol shortage, many anesthesia providers complained that the IV sedative-hypnotic's large, single-use-only vials led to excessive waste after short cases that required only small amounts of the drug. With the introduction of propofol packaged in smaller vials, however, a German pharmaceutical manufacturer has introduced an effective solution.

Fresenius Kabi is offering its Diprivan (propofol) injectable emulsion, USP, in 10mL vials, the first drug maker to do so. The company received FDA approval for the portioning, which joins its 20-, 50- and 100mL sizes, in June.

"The Diprivan 10mL presentation is designed with consideration for common dosing practices to support single patient use and reduce waste," says John Ducker, president and CEO of the company's U.S. division in Lake Zurich, Ill., in a statement. "This is particularly important for outpatient surgery centers where lower doses are commonly administered."

The size of propofol vials became a point of contention in the lawsuits that followed the 2008 Nevada hepatitis C outbreak. Manufacturer Teva Parenteral Medicines and distributors Baxter Healthcare and McKesson Medical Surgical were ordered to pay a group of infected patients $183.6 million in October 2011 after a judge agreed that 50mL and 100mL vials marketed without single-use-only restrictions encouraged an endoscopy center's staff to reuse the vials, and consequently cross-contaminate patients.

David Bernard


Also in the News...

Is Medicare Ready to Reimburse Outpatient Knee Replacement?
$22 Million Suit: 2 Dropped Instruments Left Patient Paralyzed
Study: UV Lamps Reduce Bacteria on Computer Keyboards by 99%
Report: Anesthesiologist's Blocks Blinded 5 Cataract Patients in One Morning
Hospital That Removed Kidney From Wrong Patient Blames Referring Physician
Medical Spa Liable for Woman's SSI Death Following Liposuction
Feds: CRNA Group Offered Free Drugs to ASCs for Exclusive Contracts

New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You

News & Notes

Hep C Outbreak Doc Faces Additional Jail Time

Dipak Desai, MD, also guilty of conspiracy and fraud.

Surgeon Accused of Slapping Patients' Butts Speaks Out